• Keine Ergebnisse gefunden

Correction to: 2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function

N/A
N/A
Protected

Academic year: 2022

Aktie "Correction to: 2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Wang et al. Mol Med (2021) 27:98 https://doi.org/10.1186/s10020-021-00354-8

CORRECTION

Correction to: 2-O, 3-O desulfated

heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis

by restoring HMGB1-compromised macrophage function

Mao Wang

1

, Alex G. Gauthier

1

, Thomas P. Kennedy

2

, Haichao Wang

3

, Uday Kiran Velagapudi

1

, Tanaji T. Talele

1

, Mosi Lin

1

, Jiaqi Wu

1

, LeeAnne Daley

1

, Xiaojing Yang

1

, Vivek Patel

1

, Sung Soo Mun

1

, Charles R. Ashby Jr.

1

and Lin L. Mantell

1,3*

© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Correction to: Mol Med (2021) 27:79

https:// doi. org/ 10. 1186/ s10020- 021- 00334-y Following publication of the original article (Wang et al.

2021), the authors would like to update the Acknowl- edgements section as follows:

Acknowledgements

The authors would like to thank Dr. Kevin J. Tracey, Dr.

Ravi Sitapara and Ms. LeeAnne Daley for the insightful discussion, Dr. Sarah Oelsner for critical reading of the manuscript, and Dr. Douglas David Thomas for contrib- uting to the concept and the protocol on the involvement of NO in this project and for providing numerous feed- back on the presentation of this manuscript. A portion of the publication fee was defrayed by Chimerix Inc.

The original article has been corrected.

Author details

1 Department of Pharmaceutical Sciences, St. John’s University College of Phar- macy and Health Sciences, Queens, NY 11439, USA. 2 Wake Forest University School of Medicine, Winston Salem, NC, USA. 3 The Feinstein Institute for Medi- cal Research, Northwell Health System, Manhasset, NY, USA.

Reference

Wang M, Gauthier AG, Kennedy TP, Wang H, Velagapudi UK, Talele TT, Lin M, Wu J, Daley L, Yang X, Patel V, Mun SS, Ashby CR Jr, Mantell LL. 2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenu- ates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function. Mol Med. 2021;27:79. https:// doi. org/ 10. 1186/

s10020- 021- 00334-y.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in pub- lished maps and institutional affiliations.

Open Access Molecular Medicine

The original article can be found online at https:// doi. org/ 10. 1186/ s10020- 021- 00334-y.

*Correspondence: mantelll@stjohns.edu; lmantell@northwell.edu

1 Department of Pharmaceutical Sciences, St. John’s University College of Pharmacy and Health Sciences, Queens, NY 11439, USA

Full list of author information is available at the end of the article

Referenzen

ÄHNLICHE DOKUMENTE

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any